SUBSCRIBE
SUBSCRIBE

Texas

LATEST FROM BIOSPACE
Lone Star Bio
Deactivating A Cancer Growth Promoter, Baylor College of Medicine Study
September 29, 2008
 · 
1 min read
Lone Star Bio
Enzyme Blocks Bug-Induced Secondary Illnesses, University of Texas Southwestern Medical Center Study
September 29, 2008
 · 
1 min read
Lone Star Bio
Studies Ignite Hope for Long-Acting Allergy Vaccines; New Ragweed Regimens Would Be More Convenient And Effective, Lovelace Scientific Resources Researchers Say
September 29, 2008
 · 
1 min read
Lone Star Bio
Coming Soon: Self-Guided, Computer-Based Depression Treatment, National Space Biomedical Research Institute (NSBRI)
September 26, 2008
 · 
1 min read
Lone Star Bio
Gene Variant Boosts Risk Of Fatty Liver Disease, Scientists Discover by University of Texas Southwestern Medical Center Researchers
September 26, 2008
 · 
1 min read
Lone Star Bio
Bladder Cancer Detected Via Amplified Gene in Cells Found in Urine, University of Texas MD Anderson Cancer Center Study
September 26, 2008
 · 
1 min read
Lone Star Bio
Purifying Nanorods: Big Success With Tiny Cleanup, Rice University
September 25, 2008
 · 
1 min read
Drug Development
Novo Nordisk A/S New Diabetes Drug Liraglutide Works Well In Trial; Could Be Approved For U.S. Market By Next Year, Baylor College of Medicine Researcher Says
September 25, 2008
 · 
3 min read
Lone Star Bio
‘Baby’ Fat Cells May Be Key To Treating Obesity, Say UT Southwestern Medical Center Researchers
September 18, 2008
 · 
1 min read
Lone Star Bio
Coating Improves Electrical Stimulation Therapy Used For Parkinson’s, Depression, Chronic Pain, University of Texas Southwestern Medical Center Study
September 18, 2008
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
AustinPx Expands KinetiSol™ Technology Commercial Access through Thermo Fisher Scientific Collaboration
June 30, 2026
 · 
4 min read
Press Releases
FibroBiologics to Participate in Fireside Chat at H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
June 30, 2026
 · 
1 min read
Press Releases
Moleculin Reports Positive Phase 2/3 MIRACLE Interim Results, With Annamycin Complete Remission Rates 3-fold Greater than Control
June 30, 2026
 · 
9 min read
Press Releases
Plus Therapeutics Provides Mid-Year Business Update Including Corporate Rebranding
June 30, 2026
 · 
10 min read
Press Releases
FibroBiologics Announces Closing of up to $9.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
June 30, 2026
 · 
5 min read
Press Releases
Texas Biomed and Flyttr partner to advance next-generation solutions for the invasive New World screwworm
June 29, 2026
 · 
3 min read
Press Releases
Natera and Aveta Biomics Announce Strategic Partnership Supporting Global Phase 3 Registrational Trial of APG-157 in Head and Neck Cancer
June 29, 2026
 · 
6 min read
Press Releases
Decoy Therapeutics, Inc. Announces Up to $21 Million Private Placement Financing
June 28, 2026
 · 
5 min read
Press Releases
FibroBiologics Announces up to $9.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
June 26, 2026
 · 
6 min read
Press Releases
Medicenna Therapeutics Reports Fiscal Year 2026 Financial Results and Operational Highlights
June 26, 2026
 · 
11 min read
Load More